| Literature DB >> 35482294 |
Masahiko Nishitani-Isa1, Kojiro Mukai2, Yoshitaka Honda1,3,4, Hiroshi Nihira1, Takayuki Tanaka1, Hirofumi Shibata1, Kumi Kodama1, Eitaro Hiejima1, Kazushi Izawa1, Yuri Kawasaki5, Mitsujiro Osawa5, Yu Katata6, Sachiko Onodera6, Tatsuya Watanabe6, Takashi Uchida7, Shigeo Kure7, Junko Takita1, Osamu Ohara8, Megumu K Saito5, Ryuta Nishikomori9, Tomohiko Taguchi2, Yoji Sasahara7, Takahiro Yasumi1.
Abstract
Mutations in the C-terminal region of the CDC42 gene cause severe neonatal-onset autoinflammation. Effectiveness of IL-1β-blocking therapy indicates that the pathology involves abnormal inflammasome activation; however, the mechanism underlying autoinflammation remains to be elucidated. Using induced-pluripotent stem cells established from patients carrying CDC42R186C, we found that patient-derived cells secreted larger amounts of IL-1β in response to pyrin-activating stimuli. Aberrant palmitoylation and localization of CDC42R186C protein to the Golgi apparatus promoted pyrin inflammasome assembly downstream of pyrin dephosphorylation. Aberrant subcellular localization was the common pathological feature shared by CDC42 C-terminal variants with inflammatory phenotypes, including CDC42*192C*24 that also localizes to the Golgi apparatus. Furthermore, the level of pyrin inflammasome overactivation paralleled that of mutant protein accumulation in the Golgi apparatus, but not that of the mutant GTPase activity. These results reveal an unexpected association between CDC42 subcellular localization and pyrin inflammasome activation that could pave the way for elucidating the mechanism of pyrin inflammasome formation.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35482294 PMCID: PMC9059393 DOI: 10.1084/jem.20211889
Source DB: PubMed Journal: J Exp Med ISSN: 0022-1007 Impact factor: 17.579